Adenovirus expressing human interferon inhibits replication of foot and mouth disease virus and reduces fatal rate in mice

Journal of Bacteriology and Virology

Volumn 42, Issue 3, 2012, Pages 224-231

  Chu, Jia Qi ^a   Kim, Su Mi ^a   Lee, Kwang Nyeong ^a   Oem, Jae Ku ^a   Ko, Young Joon ^a   Lee, Hyang Sim ^a   Kim, Yong Joo ^a   Park, Jee Yong ^a   Kim, Kwang Jae ^a   Parida, Satya ^b   Oh, Yooni ^a   Paton, David J ^a   Joo, Yi Seok ^a   Kim, Byounghan ^a   Park, Jong Hyeon ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Adenovirus; FMD; Interferon; Protection

Indexed keywords

EID: 84922685635     PISSN: 15982467     EISSN: None     Source Type: Journal    
DOI: 10.4167/jbv.2012.42.3.224     Document Type: Article

References (17)

1. Bachrach HL. Foot-and-Mouth disease. Annu Rev Microbiol 1968;22:201-44.
2. th ed. Paris: OIE, 2004. p 111-28.
3. De los Santos T, Wu Q, De Avila Bottlon S, Grubman MJ. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 2005;335:222-31.
4. Moraes MP, Chinsangaram J, Brum MC, Grubman MJ. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 2003;22:268-79.
5. Sheng Feng C, Ping L, Tao S, Xin W, Guo Feng W. Construction expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus. Vet Res Commun 2003;27:243-56.
6. Zhou A, Paranjape JM, Der SD, Wiliams BR, Silverman RH. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 1999;258:435-40.
7. Stark GR, Kerr IM, Wiliams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-64.
8. Fournout S, Dozois CM, Yerle M, Pinton P, Fairbrother JM, Oswald E, et al. Cloning, chromosomal location, and tissue expression of the gene for pig interleukin-18. Immunogenetics 2000;51:358-65.
9. Qin XQ, Tao N, Dergay A, Moy P, Fawell S, Davis A, et al. Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice. Proc Natl Acad Sci U S A 1998;95:14411-6.
10. Ertl HC, Xiang Z. Novel vaccine approaches. J Immunol 1996;156:3579-82.
11. Hsu KH, Lubeck MD, Bhat BM, Bhat RA, Kostek B, Selling BH, et al. Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine 1994;12:607-12.
12. Mittal SK, McDermott MR, Johnson DC, Prevec L, Graham FL. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res 1993;28:67-90.
13. Gogev S, Georgin JP, Schynts F, Vanderplasschen A, Thiry E. Bovine herpesvirus 1 glycoprotein D expression in bovine upper respiratory tract mediated by a human adenovirus type 5. Vet Res 2004;35:715-21.
14. Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, et al. Boosting of SIV- specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants. Vaccine 2003;21:4022-35.
15. Prevec L, Schneider M, Rosenthal KL, Belbeck LW, Derbyshire JB, Graham FL. Use of human adenovirus-based vectors for antigen expression in animals. J Gen Virol 1989;70:429-34.
16. Chinsangaram J, Moraes MP, Koster M, Grubman MJ. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J Virol 2003;77:1621-5.
17. Wu Q, Brum MC, Caron L, Koster M, Grubman MJ. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J Interferon Cytokine Res 2003;23:359-68.